De Witte Jan 4
4 · RESMED INC · Filed May 22, 2025
Insider Transaction Report
Form 4
RESMED INCRMD
De Witte Jan
Director
Transactions
- Sale
ReMed Common Stock
2025-05-20$243.47/sh−2,000$486,940→ 5,806 total
Footnotes (1)
- [F1]The transaction was conducted under a Rule 10b5-1 plan adopted February 3, 2025.